Gene: ALDH1A2
Official Full Name: aldehyde dehydrogenase 1 family member A2provided by HGNC
Gene Summary: This protein belongs to the aldehyde dehydrogenase family of proteins. The product of this gene is an enzyme that catalyzes the synthesis of retinoic acid (RA) from retinaldehyde. Retinoic acid, the active derivative of vitamin A (retinol), is a hormonal signaling molecule that functions in developing and adult tissues. The studies of a similar mouse gene suggest that this enzyme and the cytochrome CYP26A1, concurrently establish local embryonic retinoic acid levels which facilitate posterior organ development and prevent spina bifida. Four transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33783 | ALDH1A2 Knockout cell line (HeLa) | Human | ALDH1A2 | 1:3~1:6 | Negative | Online Inquiry |
KO33784 | ALDH1A2 Knockout cell line (HEK293) | Human | ALDH1A2 | 1:3~1:6 | Negative | Online Inquiry |
ALDH1A2 Gene Knockout Cell Lines are a specialized set of genetically engineered cell lines that have had the ALDH1A2 gene disrupted, resulting in the complete loss of its enzymatic function. Aldehyde dehydrogenase 1A2 (ALDH1A2) is crucial for the metabolism of retinol to retinoic acid, a vital process involved in various cellular functions, including differentiation and proliferation. By utilizing these knockout cell lines, researchers can robustly investigate the consequences of ALDH1A2 depletion on cellular behavior, signaling pathways, and metabolic processes, facilitating a deeper understanding of its biological implications.
The key mechanism by which these cell lines operate lies in the absence of ALDH1A2 enzyme activity, allowing scientists to study the resulting biochemical and phenotypic changes in a controlled environment. This functional inhibition provides insight into retinoid signaling pathways and can be vital in elucidating roles in developmental biology, cancer research, and regenerative medicine.
The scientific importance of ALDH1A2 Gene Knockout Cell Lines is profound, particularly for research related to embryonic development and stem cell differentiation. Their application can extend into clinical settings by aiding in the development of therapeutic strategies targeting retinoic acid signaling pathways for diseases such as cancer and other metabolic disorders.
What sets these cell lines apart from alternatives is their high specificity and validated efficacy in disrupting the ALDH1A2 gene, ensuring reliable results in experiments. Compared to other gene-editing approaches, the full gene knockout provided by these cell lines enhances experimental rigor and reproducibility, allowing users to draw more definitive conclusions from their research.
For researchers and clinicians, the value of ALDH1A2 Gene Knockout Cell Lines lies in their ability to serve as an unparalleled tool for dissecting complex biological questions related to retinoic acid metabolism. By providing these expertly crafted models, we support the advancement of innovative research and potential therapeutic applications in various biomedical fields. Our company prides itself on delivering high-quality, rigorously validated biological products that empower scientific discovery and drive progress across research platforms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.